Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL74378 | 0.95 | SLC34A1 (0.80) | — | |
| Phosphoric Acid SCHEMBL4733558 | 0.95 | SLC34A1 (0.80) | — | |
| Phosphoric Acid SCHEMBL19326716 | 0.95 | SLC34A1 (0.80) | — | |
| Phosphoric Acid SCHEMBL7943344 | 0.95 | SLC34A1 (0.80) | — | |
| Phosphoric Acid SCHEMBL7792643 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL11505567 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL113721 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL210340 | 0.90 | SLC34A1 (0.73) | — | |
| Phosphoric Acid SCHEMBL193060 | 0.90 | SLC34A1 (0.73) | — | |
| Phosphoric Acid SCHEMBL4065840 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 728 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137717-A1 | TREATMENT FOR GINGIVITIS | THE UNIVERSITY OF MELBOURNE (AU) | 2026-05-21 | — | — | US | claimed |
| US-20260115109-A1 | STABILIZED STANNOUS COMPOSITIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2026-04-30 | — | — | US | claimed |
| US-12569417-B2 | Compositions and methods for promoting mineralization | THE UNIVERSITY OF MELBOURNE (AU) | 2026-03-10 | — | — | US | claimed |
| US-12551417-B2 | Stabilized stannous compositions | THE UNIVERSITY OF MELBOURNE (AU) | 2026-02-17 | — | — | US | claimed |
| EP-3876904-B1 | ORAL MUCOSAL CARRIER AND PROTECTANT | INSPIRED MAT STRATEGIES LLC (US) | 2025-08-20 | — | — | EP | claimed |
| CN-119185367-B | Method for biomimetically mineralizing dental enamel by using amorphous calcium phosphate nanoclusters with stable fluorine and gallic acid | 重庆大学 | 2025-06-24 | — | — | CN | claimed |
| US-12303548-B2 | Complexes for treating sensitivity | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-20 | — | — | US | claimed |
| US-20250152482-A1 | STABILIZED STANNOUS COMPOSITIONS | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-15 | — | — | US | claimed |
| US-20250152666-A1 | COMPLEXES FOR TREATING SENSITIVITY | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-15 | — | — | US | claimed |
| WO-2025097213-A1 | COMPOSITIONS AND METHODS FOR TREATING HALITOSIS | THE UNIVERSITY OF MELBOURNE (AU) | 2025-05-15 | — | — | WO | claimed |
| US-5981475-A | DENTINAL HYPERSENSITIVITY REDUCING AGENT CONTAINING A CASEIN, A COMPONENT OF CASEIN, A PHOSPHOPROTEIN AND A PHOSPHOPEPTIDE, COMPRISING AMINO ACYL RESIDUES OF PHOSPHOSERIN, PHOSPHOLYSIN,POHSOPHOTHREONINE, PHOSPHOTYROSINE, | THE UNIVERSITY OF MELBOURNE (AU) | 1999-11-09 | — | — | US | claimed |
| WO-1998040406-A1 | CALCIUM PHOSPHOPEPTIDE COMPLEXES | THE UNIVERSITY OF MELBOURNE (AU) | 1998-09-17 | — | — | WO | claimed |
| EP-0651652-A4 | TREATMENT FOR SENSITIVE TEETH. | UNIV MELBOURNE (AU) | 1996-10-23 | — | — | EP | claimed |
| US-5437857-A | A deposited apatite is formed on teeth in situ after applying a mixed solution of amorphous calcium compound and a material forming amorphous calcium phosphate, calcium phosphate fluoride or calcium carbonate phosphate | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1995-08-01 | — | — | US | claimed |
| EP-0651652-A1 | TREATMENT FOR SENSITIVE TEETH | THE UNIVERSITY OF MELBOURNE (AU) | 1995-05-10 | — | — | EP | claimed |
| EP-0628017-A1 | METHODS AND COMPOSITIONS FOR MINERALIZING AND FLUORIDATING CALCIFIED TISSUES | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1994-12-14 | — | — | EP | claimed |
| WO-1994004460-A1 | METHODS AND COMPOSITIONS FOR MINERALIZING AND FLUORIDATING CALCIFIED TISSUES | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1994-03-03 | — | — | WO | claimed |
| WO-1994000146-A1 | TREATMENT FOR SENSITIVE TEETH | THE UNIVERSITY OF MELBOURNE (AU) | 1994-01-06 | — | — | WO | claimed |
| US-5268167-A | Dental restorative; amorphous calcium phosphate fluoride and carrier | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1993-12-07 | — | — | US | claimed |
| US-4707273-A | Manganese removal from aqueous industrial waste effluents | AMCHEM PRODUCTS (US) | 1987-11-17 | — | — | US | claimed |